Osteopenia after TSH inhibition therapy for postmenopausal differentiated thyroid carcinoma
Conditions
Interventions
Experimental group:99Tc-MDP and calcium
control group:calcium
Sponsors
Shanghai Tenth People's Hospital
Eligibility
Sex/Gender
Female
Age
No minimum to 65 Years
Inclusion criteria
Inclusion criteria: 1. Postmenopausal women; 2. After the operation of differentiated thyroid carcinoma (pathological diagnosis), TSH suppression therapy (TSH = -2.5 SD.
Exclusion criteria
Exclusion criteria: 1. Patients refused to participate in the study; 2. Allergic to remazolam, propofol, butorphanol and other drug ingredients or components that may be used in the study; 3. Patients with other serious respiratory and circulatory diseases; 4. Suffering from mental system diseases (such as schizophrenia, etc.) and cognitive dysfunction; A history of epilepsy; A past history of abuse of psychotropic drugs and narcotic drugs; 5. Subjects who received general anesthesia within 7 days; 6. Patients who may be affected by alcohol, drugs or drug withdrawal; 7. Other conditions that are not suitable for the study, such as patients with expected difficulty in intubation, were assessed by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anesthetic effect;State-trait Anxiety Scale score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative Visual Analogue Scale (VAS) score;Incidence of intraoperative respiratory and circulatory depression;Awake time; | — |
Countries
China
Contacts
Public ContactChao Ma
Shanghai Tenth People's Hospital
Outcome results
None listed